Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.08.002Source: DataRank Database

The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis is a research paper published in Journal of Cystic Fibrosis (2023). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.94)OA: greenTopics (49)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Anna Faino ORCID,Gracia Bridges,Lauren Bartlett ORCID,Jonathan D. Cogen ORCID,Nicole Green ORCID

Live enrichment

PubMed:37563007 PMC:PMC10843772 OpenAlex:https://openalex.org/W4385650892

Cystic Fibrosis Foundation

Grant: HERGEN22D0

Cystic Fibrosis Foundation

Grant: RAMOS17A0

Cystic Fibrosis Foundation

Grant: SINGH19R0

National Institutes of Health

Grant: DK089507

NIDDK NIH HHS

Grant: P30 DK089507

FWCI

4.94

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10843772/pdf/nihms-1923601.pdf

publisherhttps://api.elsevier.com/content/article/PII:S156919932300869X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S156919932300869X?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10843772

Fields of Study

Cystic Fibrosis Research AdvancesAsthma and respiratory diseasesAntioxidant Activity and Oxidative StressHumansVitamin ACystic FibrosisRetrospective StudiesVitaminsVitamin DVitamin ECystic Fibrosis Transmembrane Conductance RegulatorAminophenolsBenzodioxolesMutationPyrazolesPyridinesPyrrolidinesQuinolonesIndoles

MeSH Terms

AminophenolsCystic FibrosisHumansIndolesMutationPyrazolesPyridinesPyrrolidinesRetrospective StudiesVitamin AVitamin DVitamin EVitaminsQuinolonesCystic Fibrosis Transmembrane Conductance RegulatorBenzodioxoles

Keywords

MedicineCystic fibrosisVitamin D and neurologyVitaminIvacaftorInternal medicinePhysiologyGastroenterologyCystic fibrosis transmembrane conductance regulatorHypervitaminosis APancreatic InsufficiencyEtiVitamin LevelsElexacaftor/Tezacaftor/Ivacaftor